Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants-Reference-Cited by-同舟云学术

Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants

Published:2002-12 Issue:12 Volume:8 Page:656-661
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bacigalupo A,Lamparelli T,Gualandi F,Bregante S,M. Raiola A,Di Grazia C,Dominietto A,Bruno B,Galbusera V,Frassoni F,Podesta M,Tedone E,Occhini D,Van Lint M.T

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults;Cochrane Database of Systematic Reviews;2023-06-21

2. Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants;The Journal of Immunology;2022-05-01

3. Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival;Clinical Lymphoma Myeloma and Leukemia;2021-09

4. Novel Approach for Bone Marrow Transplantation Conditioning in Acute Myelogenous Leukemia not Responding to the Induction Therapy Using Etoposide Carried in Lipid Core Nanoparticles: A Pilot Clinical Study;Biology of Blood and Marrow Transplantation;2020-11

5. Immunology and Immunotherapy of Graft-Versus-Host Disease;Cancer Immunology;2020